APA Citatie

Friess, H., Langrehr, J. M., Oettle, H., Raedle, J., Niedergethmann, M., Dittrich, C., . . . Nippgen, J. (2006). A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer. BioMed Central.

Chicago Style citaat

Friess, Helmut, et al. A Randomized Multi-center Phase II Trial of the Angiogenesis Inhibitor Cilengitide (EMD 121974) and Gemcitabine Compared With Gemcitabine Alone in Advanced Unresectable Pancreatic Cancer. BioMed Central, 2006.

MLA citatie

Friess, Helmut, et al. A Randomized Multi-center Phase II Trial of the Angiogenesis Inhibitor Cilengitide (EMD 121974) and Gemcitabine Compared With Gemcitabine Alone in Advanced Unresectable Pancreatic Cancer. BioMed Central, 2006.

Let op: Deze citaties zijn niet altijd 100% accuraat.